Us Bancorp \De\ Biocryst Pharmaceuticals Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 210 shares of BCRX stock, worth $1,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

210

Holding current value

$1,965

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$7.03 - $8.43 $1,476 - $1,770	210 New	210 $1,000
Q1 2023 May 09, 2023	BUY	$7.94 - $11.84 $8,273 - $12,337	1,042 Added 1240.48%	1,126 $9,000
Q4 2022 Feb 13, 2023	SELL	$10.5 - $14.2 $283 - $383	-27 Reduced 24.32%	84 $0
Q3 2022 Oct 27, 2022	BUY	$10.79 - $14.81 $291 - $399	27 Added 32.14%	111 $1,000
Q2 2022 Aug 01, 2022	SELL	$7.89 - $17.88 $94,806 - $214,846	-12,016 Reduced 99.31%	84 $1,000
Q1 2022 May 11, 2022	BUY	$11.56 - $19.76 $5,780 - $9,880	500 Added 4.31%	12,100 $197,000
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $33,607 - $46,472	3,006 Added 34.98%	11,600 $161,000
Q3 2021 Nov 10, 2021	BUY	$14.21 - $17.65 $2,756 - $3,424	194 Added 2.31%	8,594 $123,000
Q2 2021 Aug 05, 2021	SELL	$9.5 - $17.24 $28,500 - $51,719	-3,000 Reduced 26.32%	8,400 $133,000
Q1 2021 Apr 28, 2021	BUY	$7.37 - $13.61 $69,278 - $127,934	9,400 Added 470.0%	11,400 $116,000
Q4 2020 Feb 04, 2021	BUY	$3.37 - $8.61 $6,740 - $17,220	2,000 New	2,000 $15,000
Q3 2020 Nov 10, 2020	SELL	$3.43 - $5.53 $3,430 - $5,530	-1,000 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$1.9 - $5.61 $1,900 - $5,610	1,000 New	1,000 $5,000
Q4 2019 Feb 04, 2020	SELL	$1.59 - $3.45 $7,390 - $16,035	-4,648 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.91 - $9.15 $12,518 - $39,363	4,302 Added 1243.35%	4,648 $18,000
Q1 2019 May 08, 2019	BUY	$7.38 - $9.72 $2,553 - $3,363	346 New	346 $3,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

167M

Call Options Held

728K

Put Options Held

989K

Vanguard Group Inc Valley Forge, PA

21.9M
Shares

$205 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$187 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$111 Million
1.3% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$85 Million
4.33% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

8.14M
Shares

$76.2 Million
1.52% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.74B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account